LVAMX
Price
$10.94
Change
+$0.06 (+0.55%)
Updated
Jun 2 closing price
Net Assets
27.48M
RWEBX
Price
$68.25
Change
+$0.27 (+0.40%)
Updated
Jun 2 closing price
Net Assets
214.46B
Interact to see
Advertisement

LVAMX vs RWEBX

Header iconLVAMX vs RWEBX Comparison
Open Charts LVAMX vs RWEBXBanner chart's image
LVAMX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
LVAMX vs. RWEBX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVAMX is a Buy and RWEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 214B vs. LVAMX (27.5M). LVAMX pays higher dividends than RWEBX: LVAMX (1.44) vs RWEBX (0.75). LVAMX was incepted earlier than RWEBX: LVAMX (12 years) vs RWEBX (12 years). LVAMX (1.22) is less costly to investors than RWEBX (1.06). LVAMX (30.00) and RWEBX (29.00) have comparable annual turnover. RWEBX has a lower initial minimum investment than LVAMX: RWEBX (250) vs LVAMX (1000). RWEBX annual gain was more profitable for investors over the last year : 7.24 vs. LVAMX (1.86). RWEBX return over 5 years is better than : 22.77 vs. LVAMX (-9.98).
LVAMXRWEBXLVAMX / RWEBX
Total Expense Ratio0.801.0675%
Annual Report Gross Expense Ratio1.221.06115%
Fund Existence12 years12 years-
Gain YTD11.7045.239223%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets27.5M214B0%
Annual Yield % from dividends1.440.75191%
Returns for 1 year1.867.2426%
Returns for 3 years2.0729.987%
Returns for 5 years-9.9822.77-44%
Returns for 10 years19.4378.6225%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVASX38.87N/A
N/A
JPMorgan Value Advantage I
RTSAX46.98N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap A
ETHSX12.26N/A
N/A
Eaton Vance Worldwide Health Sci A
GVCAX12.36N/A
N/A
Gabelli Value 25 AAA
MDOEX12.67N/A
N/A
Morgan Stanley Developing Opportunity I